Navigation Links
Lilly Quality Leader Walsh Appointed to Company's Executive Committee
Date:7/1/2011

INDIANAPOLIS, July 1, 2011 /PRNewswire/ -- Fionnuala Walsh, Ph.D., will join the executive committee of Eli Lilly and Company (NYSE: LLY) on July 1.

Walsh will continue in her current role as Lilly's senior vice president of global quality, reporting to John Lechleiter, Ph.D., chairman, president, and CEO, and working to ensure Lilly continues to maintain high quality standards across its worldwide operations.

Walsh is a recognized thought leader in the quality industry, often speaking about Lilly's sustainable, integrated quality system and the company's commitment to maintaining a quality culture. Her presence on the company's most senior governance committee is expected to further underscore Lilly's ongoing commitment to quality.

A native of Ireland, Walsh earned a bachelor's degree and doctoral degree in chemistry from University College Dublin. She joined Lilly's Kinsale, Ireland, manufacturing site in 1988 as a technical services chemist. After numerous positions there, she moved into a role as global quality leader at the Lilly Corporate Center in Indianapolis in 2002.

In January 2003, Walsh was named executive director of quality for U.S. drug product and Lilly Technology Center operations. In July 2005, she was named vice president of global quality operations, and, in June 2007, she was named senior vice president of global quality.

About Eli Lilly and Company

Lilly, a leading, innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers—through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... SAN ANTONIO , Sept. 2, 2014 /PRNewswire/ ... private medical technology company focused on innovating lifesaving ... announced the appointment of Dr. Gabriele Niederauer ... President and CEO. Following the recent closure of ... CE Mark for the Surfacer™ Inside-Out Access Catheter ...
(Date:9/2/2014)... , Sept. 2, 2014   Veracyte, Inc. (Nasdaq: ... Anderson , president and chief executive officer, will present in ... Healthcare Unplugged Conference 2014 on Monday, September 8, 2014 at ... The live audio webcast and subsequent replay may ... Please connect to the website at least 15 minutes prior ...
(Date:9/2/2014)... Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... its lipid franchise were highlighted in four presentations at ... Barcelona Spain . Isis has created ... effective and safe therapeutic options to treat patients with ... drug and several other drugs in clinical development designed ...
Breaking Medicine Technology:Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President And CEO 2Veracyte to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2014 2Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 2Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 3Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 4Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 5
... , the leading online Medical Transcription and Editing training ... NexGen Speech Recognition Editing and Medical Transcription Program. In ... MTEC is moving their curriculum to the next level. ... this important industry migration and is being provided to ...
... Medical Messenger , an innovative healthcare technology ... 4 is now certified to meet 2011-2012 criteria supporting ... and Reinvestment Act (ARRA) as a Complete EHR by ... record (EHR) software capable of enabling providers to meet ...
Cached Medicine Technology:MTEC Announces Release of NexGen Speech Recognition Editing and Medical Transcription Training Program 2Medical Messenger's AstralJet V4 Receives ONC-ATCB 2011/2012 Certification 2
(Date:9/2/2014)... (PRWEB) September 02, 2014 The global ... USD 8,918.8 million by 2020, growing at an estimated ... a new study by Grand View Research, Inc. Peripheral ... plague modification devices are used for treating peripheral arterial ... of atherosclerotic plaques in arteries. These devices are used ...
(Date:9/2/2014)... 02, 2014 Researchers in New Delhi, India ... mesothelioma after being exposed to asbestos-contaminated work clothes for just ... details of the report in a new article. Click ... ESI Model Hospital say their patient was diagnosed with ... investigation found that she had come in contact with her ...
(Date:9/2/2014)... 02, 2014 MyRounding, the leader in ... been selected from a group of over 100 applicants ... PrIME Digital Health Challenge. The competition will pin Colorado’s ... Sept. 9th at the CSU Denver Atrium from 1 ... based in Denver, Colo. The cloud-based, SaaS (Software as ...
(Date:9/2/2014)... NY (PRWEB) September 02, 2014 Eric ... Color Me , a revolutionary makeup application device. ... puts clinically proven innovation in the palm of women’s ... , The secret to Color Me’s success lies in ... runs at a rate of 15,000 pulses per minute, ...
(Date:9/2/2014)... Headaches, both chronic and acute ruin lives. They ... and friends, sleeping and just coping well with daily activities. ... disability worldwide. The medications prescribed for these conditions frequently ... these cases of headache and back pain are of a ... not detect and fix the cause. , When a ...
Breaking Medicine News(10 mins):Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 3Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 4Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 5Health News:New Report Illustrates That Even Brief Asbestos Exposure Can Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:MyRounding Selected for Digital Health Venture Showcase Finals Top Three Startups Awarded $50,000 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 3Health News:Physical Therapists in Houston Learn Pain Relief Techniques 2
... -- There are major differences between oncologists and primary ... care for American,s 12 million cancer survivors. That ... survey of doctors that reveals how these differences pose ... following initial cancer treatment. The study, published online ...
... When looking at a picture of many trees, young people ... we get, the more likely we are to notice a single ... which the brain processes the bigger picture is slower in older ... Elseviers Cortex , researchers have found that these age-related changes ...
... , SUNDAY, July 24 (HealthDay News) -- Young children ... so parents should be especially vigilant monitoring their kids around ... Centre of The Montreal Children,s Hospital also warned that toddlers ... to recognize potential dangers at a pool. Mandatory fencing ...
... By Steven Reinberg HealthDay Reporter , SUNDAY, July ... a new anti-clotting drug, Eliquis, to dual antiplatelet therapy may ... attack and stroke, a new study finds. A trial ... of severe bleeding among those taking Eliquis (apixaban) became apparent. ...
... HealthDay Reporter , FRIDAY, July 22 (HealthDay News) ... difficulty understanding medical information, your health may be at risk. ... that low health literacy is linked with many types of ... "There are no real surprises here," said study author Nancy ...
... News) -- Eager young athletes will be taking to sports ... to be protected from heat exhaustion and heat stroke, a ... safe is "hydration, hydration, hydration," Dr. Toni Salvatore, medical director ... in a hospital news release. Drinking adequate amounts of ...
Cached Medicine News:Health News:Study: Doctors differ in how best to care for America's 12 million cancer survivors 2Health News:Study: Doctors differ in how best to care for America's 12 million cancer survivors 3Health News:Older people find it harder to see the wood for the trees 2Health News:Anti-Clotting Drug May Cause Severe Bleeding With No Benefit 2Health News:Anti-Clotting Drug May Cause Severe Bleeding With No Benefit 3Health News:Low 'Health Literacy' Hazardous to Your Health 2
... CONMED's family of products allows you to ... generators feature proprietary Energy Synchronous Processing Technology. ... current and voltage in all operational modes. ... to sample current and voltage over 450,000 ...
... achieves a secure clot, targeted to the ... hemostasis is needed, when control of bleeding ... and cautery, is ineffective or impractical., CROSSEAL* ... of human Biologically Active Component (BAC) and ...
GluStitch® is indicated for the closure of uncomplicated skin lacerations where there is little or no tissue loss....
... pacemaker family offers some ... automatic devices. Featuring the ... advanced technologies ever seen, ... incorporates the exclusive ventricular ...
Medicine Products: